par Simon, Bernd;Porro, Gabriele Bianchi;Cremer, Michel
;Dobrilla, Giorgio;Haglund, U.;Dunn, S.L.;Summers, D.K.
Référence Journal of clinical gastroenterology, 8, 3, page (367-370)
Publication Publié, 1986
;Dobrilla, Giorgio;Haglund, U.;Dunn, S.L.;Summers, D.K.Référence Journal of clinical gastroenterology, 8, 3, page (367-370)
Publication Publié, 1986
Article révisé par les pairs
| Résumé : | Six hundred and five patients with endoscopically diagnosed duodenal ulcer were randomly allocated to treatment with ranitidine 300 mg at night or ranitidine 150 mg twice daily in a prospective double-blind multicenter trial conducted in nine European countries. Endoscopy at 4 weeks showed complete ulcer healing in 246 of 301 patients (82%) treated with ranitidine 150 mg b.i.d. and 230 of 304 patients (76%) treated with ranitidine 300 mg at night. Cumulative healing rates at 8 weeks were 95 and 94% respectively. Both treatment regimens were equally effective at rapidly reducing the incidence of ulcer-related symptoms. Adverse events were few and consistent with those reported in previous studies with ranitidine 150 mg twice daily. The results of this trial indicate that a single nighttime dose of ranitidine is an effective and safe alternative to the twice daily regimen in the acute treatment of duodenal ulcer. © 1986 Raven Press, New York. |



